Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H42N2O5S |
Molecular Weight | 506.698 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C3=CSC(C)=N3
InChI
InChIKey=FABUFPQFXZVHFB-PVYNADRNSA-N
InChI=1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1
Molecular Formula | C27H42N2O5S |
Molecular Weight | 506.698 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:20:19 UTC 2023
by
admin
on
Sat Dec 16 16:20:19 UTC 2023
|
Record UNII |
K27005NP0A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK547985
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
||
|
NCI_THESAURUS |
C2584
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
||
|
NDF-RT |
N0000175085
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
||
|
WHO-VATC |
QL01DC04
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
||
|
NDF-RT |
N0000175592
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
||
|
WHO-ATC |
L01DC04
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
747973
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
337523
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | RxNorm | ||
|
DB04845
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
K27005NP0A
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
SUB33513
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
K27005NP0A
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
DTXSID70870252
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
OO-38
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
100000127487
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
6445540
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
219989-84-1
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
6824
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201752
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
63605
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
1517
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
1354400
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
C430592
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
m6567
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | Merck Index | ||
|
7738
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
C37452
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
IXABEPILONE
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY | |||
|
8390
Created by
admin on Sat Dec 16 16:20:20 UTC 2023 , Edited by admin on Sat Dec 16 16:20:20 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
BINDER->LIGAND |
The percentages ixabepilone bound to proteins at concentrations of 50, 500 and 5000 ng/mL were 76.6%, 72.0% and 67.1%, respectively. The protein binding of ixabepilone was not concentration dependent from 50 ng/mL to 5000 ng/mL.
BINDING
|
||
|
EXCRETED UNCHANGED |
AMOUNT EXCRETED
FECAL
|
||
|
PARENT -> DERIVATIVE |
|
||
|
EXCRETED UNCHANGED |
AMOUNT EXCRETED
URINE
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
PLASMA
|
||
|
METABOLITE -> PARENT |
FECAL; PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
FECAL
|
||
|
METABOLITE -> PARENT |
FECAL; PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||